SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Accelmed Growth Partners, L.P. (Last) (First) (Middle) 6 HACHOCHLIM STREET, 6TH FLOOR (Street) HERZLIYA PITUACH L3 46120 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 05/29/2018	3. Issuer Name and Ticker or Trading Symbol STRATA Skin Sciences, Inc. [ SSKN ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $0.001 par value per share	12,037,037	D(1)
Common Stock, $0.001 par value per share	12,037,037	I	By: Accelmed Growth Partners (GP), L.P.(1)
Common Stock, $0.001 par value per share	12,037,037	I	By: Accelmed Growth Partners (AGP) Ltd.(1)
Common Stock, $0.001 par value per share	12,037,037	I	By: Accelmed Growth Partners Management Ltd.(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* Accelmed Growth Partners, L.P. (Last) (First) (Middle) 6 HACHOCHLIM STREET, 6TH FLOOR (Street) HERZLIYA PITUACH L3 46120 (City) (State) (Zip)

1. Name and Address of Reporting Person* Accelmed Growth Partners (GP), L.P. (Last) (First) (Middle) 6 HACHOCHLIM STREET, 6TH FLOOR (Street) HERZLIYA PITUACH L3 46120 (City) (State) (Zip)

1. Name and Address of Reporting Person* Accelmed Growth Partners (AGP) Ltd (Last) (First) (Middle) 6 HACHOCHLIM STREET, 6TH FLOOR (Street) HERZLIYA PITUACH L3 46120 (City) (State) (Zip)

1. Name and Address of Reporting Person* Accelmed Growth Partners Management Ltd. (Last) (First) (Middle) 6 HACHOCHLIM STREET, 6TH FLOOR (Street) HERZLIYA PITUACH L3 46120 (City) (State) (Zip)

Explanation of Responses:

1. These shares are held directly by Accelmed Growth Partners, L.P. and may be deemed to be beneficially owned indirectly by (i) Accelmed Growth Partners (GP), L.P., the general partner of Accelmed Growth Partners, L.P., (ii) Accelmed Growth Partners (AGP) Limited, the general partner of Accelmed Growth Partners (GP), L.P., and (iii) Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the shares pursuant to a management agreement. Each of Accelmed Growth Partners (GP), L.P., Accelmed Growth Partners (AGP) Limited, and Accelmed Growth Partners Management Ltd. disclaims such beneficial ownership except to the extent of its pecuniary interest in the shares.

Remarks:

	Accelmed Growth Partners, L.P. By: Accelmed Growth Partners (GP), L.P., its general partner By: Accelmed Growth Partners (AGP) Ltd., its general partner By: /s/ Uri Geiger, Managing Partner	05/31/2018
	Accelmed Growth Partners (GP), L.P. By: Accelmed Growth Partners (AGP) Ltd., it general partner By: /s/ Uri Geiger, Managing Partner	05/31/2018
	Accelmed Growth Partners (AGP) Ltd. By: /s/ Uri Geiger, Managing Partner	05/31/2018
	Accelmed Growth Partners Management Ltd. By: /s/ Uri Geiger, Managing Partner	05/31/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.